Detalles de la búsqueda
1.
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
BMC Cancer
; 16: 69, 2016 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26857924
2.
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
BMC Cancer
; 14: 875, 2014 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25421252
3.
Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial.
Oncotarget
; 6(30): 30394-407, 2015 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320185
4.
Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
Int J Oncol
; 21(5): 941-8, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12370739
Resultados
1 -
4
de 4
1
Próxima >
>>